Related Experiment Video
Updated: Jul 26, 2026
07:10
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
Variable and conserved neutralization antigens of human immunodeficiency virus
Nature
|December 11, 1986
Summary
Human immunodeficiency virus type 1 (HIV-1) shows genetic diversity. Human sera can neutralize various HIV-1 strains, suggesting conserved epitopes for vaccine development.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Human immunodeficiency virus type 1 (HIV-1) exhibits significant genetic polymorphism, especially within the env gene.
- This genetic diversity poses challenges for developing effective vaccines and treatments against acquired immune deficiency syndrome (AIDS).
Purpose of the Study:
- To investigate the neutralizing capacity of antibodies against genetically diverse HIV-1 isolates.
- To identify conserved antigenic epitopes on HIV-1 that can elicit cross-neutralizing antibodies.
Main Methods:
- Sera from immunized rabbits, guinea pigs, and HIV-1-infected individuals were tested.
- Neutralization assays were performed using a panel of genetically divergent HIV-1 isolates.
Main Results:
- Antibodies against a recombinant env glycoprotein (gp130) primarily neutralized the homologous virus strain.
- Human sera demonstrated cross-neutralization of multiple HIV-1 isolates, indicating the presence of conserved epitopes.
- Neutralization titres were not significantly affected by human complement.
Conclusions:
- Genetically diverse HIV-1 isolates possess both variable and conserved antigenic epitopes targeted by neutralizing antibodies.
- The identification of shared epitopes is crucial for the development of broadly protective HIV-1 vaccines.
More Related Videos
Related Concept Videos
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...